Skip to main content

Ebola Vaccine Could Be Ready in Africa Soon

The World Health Organization says a trial Ebola Fever Immunogen has been observed to be amazingly defensive against the ferocious infection in a major trial in Guinea

Ebola
"The immunization is the first to keep contamination from a standout amongst the most deadly known pathogens, and the discoveries add weight to early trial comes about distributed a year ago," WHO said in a public statement.

The UN health agency noticed the aftereffects of the most recent trial distributed on Friday in the restorative diary The Lancet.

As indicated by WHO, the vaccine, 'rVSV-ZEBOV', was considered in a trial involving 11,841 individuals in Guinea during 2015.

It said among the 5,837 people who received the vaccine, no Ebola cases were recorded 10 days or more after vaccination.

In comparison, there were 23 cases in 10 days or more after vaccination among those who did not receive the vaccine, the global health organisation said.

The report quoted Dr. Marie-Paule Kieny, WHO’s Assistant Director-General for Health Systems and Innovation, and the study’s lead author, as saying the result was “defensive” against future Ebola outbreaks.

"While these compelling results come too late for those who lost their lives during West Africa’s Ebola epidemic, they show that when the next Ebola outbreak hits, we will not be defenceless," Kieny said.

The Ebola infection was initially recognized in 1976 and brought on sporadic outbreaks in Africa.

However, the 2013-2016 outbreaks in West Africa that killed more than 11,300 people underlined the urgent need of a vaccine.

Guinea, along with Liberia and Sierra Leone, was one of the worst affected countries.

Dr KeÏta Sakoba, the Coordinator of the Ebola Response and Director of Guinea’s National Agency for Health Security, noted the significance of the latest results.

“We are proud that we have been able to contribute to developing a vaccine that will prevent other nations from enduring what we endured,” Sakoba said.

The reports said the trial took place in the coastal region of Basse-Guinée, the area of Guinea still experiencing new Ebola cases when the trial started in 2015.

"It employed an innovative design, a so-called `ring vaccination' approach – the same method used to eradicate small pox.

"This involved tracing all people who may have been in contact with a new Ebola case within the previous three weeks as well as certain contacts of contacts."

In addition to showing high efficacy among those vaccinated, it said the trial also shows that unvaccinated people in the rings were indirectly protected from Ebola virus through the ring vaccination approach.

However, the authors noted that the trial was not designed to measure this effect, so more research will be needed.

Comments

Post a Comment

Say something about this

Popular posts from this blog

Amazon plans to lay off about 10,000 employees starting this week

Amazon.com Inc is planning to lay off about 10,000 people in corporate and technology jobs starting as soon as this week, the New York Times reported on Monday, citing people with knowledge of the matter. The cuts will focus on the e-commerce giant's devices unit, which houses voice-assistant Alexa, as well as its retail division and human resources, according to the report, which also said the total number of layoffs remains fluid. The company did not immediately respond to a Reuters request for comment. As of Dec. 31 last year, Amazon had about 1,608,000 full-time and part-time employees. Amazon joins a bandwagon of U.S. companies making deep cuts to its employee base to brace for a potential economic downturn. Rad also:  Tech Boot Camp: Cadbury Nigeria Empowers over 9000 Kids Last week, Facebook-parent Meta Platforms said it would cut more than 11,000 jobs, or 13% of its workforce, to rein in costs. (Reporting by Tiyashi Datta in Bengaluru; Editing by Arun Koyyur)

Prices of Maize, Rice and other food commodities to rise in December, 2022 – Survey

One of Nigeria’s commodities market players, AFEX has forecasted a surge in prices of six food commodities, namely maize, paddy rice, sorghum, soybean, cocoa and sesame by the end of December 2022 to the first half of 2023. AFEX’s forecast is contained in its 2022 Wet Season Crop Production Report unveiled at a hybrid event hosted at the firm’s head office in Abuja on Wednesday. The report said maize which faces a projected decline in production levels of up to 14% will reach a higher average price point ranging between N214, 980/metric ton ($486.72) and N220,000/metric ton ($498.09) by the end of the fourth quarter (Q4) 2022. According to the report, this is compared to an average price of ($475.97) N210, 229/metric ton in Q4 2021, and projected that soybean price will rise by 6% by May 2023. David Ibidapo, AFEX head of market data and research who presented the report said annual crop production research seeks to provide robust market intelligence for agriculture value chain player

Photos: Papa Ajasco opens baby factory

Papa Ajasco & Company, Nigeria’s Most Watched TV Comedy, has commenced a new season of amusing adventures, including a story in which Papa Ajasco, Pa James, Miss Pepeye, Boy Alinco, and Mama Ajasco establish and operate an illegal ‘Baby Factory’; with hilarious consequences. According to the Managing Director of WAP,Wale Adenuga Jr.,“This new season of PAPA AJASCO & COMPANY is packed with several entertaining stories. They really get themselves into some tight situations; but these experiences always leave them, as well as the viewers,with new important lessons and of course uncontrollable laughter.”